Q32 Bio Inc. (NASDAQ:QTTB) Shares Acquired by State Street Corp

Dec 30, 2024 · State Street Corp boosted its stake in Q32 Bio Inc. (NASDAQ:QTTB – Free Report) by 35.5% during the 3rd quarter, according to its most recent Form 13F filing with the …

5%
OFF

Q32 Bio Inc. (NASDAQ:QTTB) Shares Acquired By State Street Corp

2 weeks from now

Dec 30, 2024 · State Street Corp boosted its stake in Q32 Bio Inc. (NASDAQ:QTTB – Free Report) by 35.5% during the 3rd quarter, according to its most recent Form 13F filing with the …

etfdailynews.com

5%
OFF

Q32 Bio Inc. (NASDAQ:QTTB) Shares Bought By State Street Corp

2 weeks from now

Dec 30, 2024 · State Street Corp grew its stake in shares of Q32 Bio Inc. (NASDAQ:QTTB – Free Report) by 35.5% in the 3rd quarter, according to its most recent filing with the Securities & …

defenseworld.net

5%
OFF

Q32 Bio Inc. (NASDAQ:QTTB) Holdings Increased By Barclays PLC

2 weeks from now

Jan 3, 2025 · Jane Street Group LLC acquired a new stake in Q32 Bio in the third quarter worth approximately $733,000. State Street Corp raised its stake in shares of Q32 Bio by 35.5% in …

defenseworld.net

5%
OFF

Q32 Bio Inc. (NASDAQ:QTTB) Given Average Rating Of “Moderate …

2 weeks from now

Dec 25, 2024 · Finally, State Street Corp grew its stake in shares of Q32 Bio by 35.5% during the third quarter. State Street Corp now owns 110,164 shares of the company’s stock worth …

americanbankingnews.com

$733000
OFF

BMO Capital Markets Issues Pessimistic Forecast For Q32 Bio …

2 weeks from now

Dec 15, 2024 · Jane Street Group LLC acquired a new position in shares of Q32 Bio in the 3rd quarter worth $733,000. Finally, State Street Corp grew its holdings in shares of Q32 Bio by …

etfdailynews.com

5%
OFF

Q32 Bio (NASDAQ:QTTB) Rating Lowered To Hold At Leerink Partnrs

2 weeks from now

Dec 12, 2024 · Finally, State Street Corp grew its holdings in Q32 Bio by 35.5% during the third quarter. State Street Corp now owns 110,164 shares of the company's stock valued at …

marketbeat.com

$24.41
OFF

Fmr LLC Purchases 246,664 Shares Of Q32 Bio Inc. (NASDAQ:QTTB)

2 weeks from now

Dec 11, 2024 · View Our Latest Report on Q32 Bio. Q32 Bio Price Performance. NASDAQ QTTB opened at $24.41 on Wednesday. Q32 Bio Inc. has a 12 month low of $9.54 and a 12 month …

defenseworld.net

32%
OFF

Q32 Bio Inc. (NASDAQ:QTTB) Shares Purchased By Fmr LLC

2 weeks from now

Dec 11, 2024 · Finally, Renaissance Technologies LLC acquired a new position in Q32 Bio in the 2nd quarter valued at $265,000. Institutional investors and hedge funds own 31.32% of the …

marketbeat.com

FAQs about Q32 Bio Inc. (NASDAQ:QTTB) Shares Acquired by State Street Corp Coupon?

Who owns q32 bio?

Franklin Resources Inc. bought a new stake in Q32 Bio during the third quarter worth approximately $225,000. Barclays PLC lifted its position in shares of Q32 Bio by 105.2% during the 3rd quarter. Barclays PLC now owns 10,443 shares of the company’s stock valued at $465,000 after acquiring an additional 5,353 shares during the last quarter. ...

How many insiders own q32 bio (QTb) stock?

In the past three months, Q32 Bio insiders have not sold or bought any company stock. 16.10% of the stock of Q32 Bio is held by insiders. A high percentage of insider ownership can be a sign of company health. Only 31.32% of the stock of Q32 Bio is held by institutions. Receive QTTB Stock News and Ratings via Email ...

When will q32 bio (qttb) start trading?

The combined company will operate under the name Q32 Bio, and its shares are expected to begin trading on the Nasdaq Global Market on March 26, 2024, under the ticker symbol "QTTB". ...

Is q32 bio a good stock to buy?

Four equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. Based on data from MarketBeat.com, Q32 Bio currently has a consensus rating of “Moderate Buy” and a consensus target price of $29.86. ...

Is q32 bio a'market perform' stock?

Leerink Partners reissued a “market perform” rating and issued a $9.00 price target (down previously from $68.00) on shares of Q32 Bio in a research note on Wednesday. Piper Sandler lowered their target price on shares of Q32 Bio from $85.00 to $20.00 and set an “overweight” rating on the stock in a research note on Wednesday. ...

What is q32 bio?

Q32 Bio Inc., a clinical-stage biotechnology company, develops biologic therapeutics to restore healthy immune balance in patients with autoimmune and inflammatory diseases driven by pathological immune dysfunction in the United States. ...